Ramanan Laxminarayan: The coming crisis in antibiotics
At the Center for Disease Dynamics, Economics & Policy, economist Ramanan Laxminarayan looks at big-picture issues of global health. Full bio
Double-click the English transcript below to play the video.
treated with an antibiotic
while working in the garden.
his head was swollen
used to treat a human,
knew if the drug would work,
that would kill the patient,
they might as well use it
his appetite came back.
run out of penicillin,
was run with his urine
the penicillin from his urine
millions of other people,
again in the early 1940s,
wonder drug, penicillin.
used rather frivolously
with just a cold or the flu,
responded to an antibiotic,
used in large quantities
means in small concentrations,
on the price of meat,
antibiotics on animals,
selection pressure on bacteria
about this in the newspapers,
of carbapenem resistance in acinetobacter.
across the United States.
when we play the video.
you might say, well,
to use antibiotics as much,
not to demand antibiotics,
fundamental about antibiotics
others are affected as well,
choose to drive to work
these costs into consideration.
call a problem of the commons,
of antibiotics as well:
that they impose on others
and climate change.
you can deal with the problem.
use of the oil that we have,
"drill, baby, drill" option,
is to go find new antibiotics.
for conservation of oil
to happen for antibiotics.
to happen, which is that
to make the investments
this particular picture,
playing against the bacteria,
ahead of the bacteria?
game that can be sustained,
can borrow from energy
the costs of pollution
which don't pollute as much
good substitutes for antibiotics?
hospital infection control
the seasonal influenza.
as in many other countries,
something like tradeable permits.
fact that we might not
people who have infections,
be on the basis of clinical need,
informational feedback,
some information back
been introduced since then —
paying 10 cents a day for antibiotics,
antibiotics as a given
looking at other technologies,
gasoline prices are a signal
seem unusual for antibiotics,
for a few months or perhaps a year,
antibiotics starts going higher,
market does actually respond,
antibiotics and development.
permanent solutions.
whatever the technology might be,
way to work around it.
this is just a problem
have the exact same
many other fields as well,
in India and South Africa.
treat malaria around the world
safe and efficacious.
know about head lice,
specialty there is bedbugs.
example from across the pond.
also resistant to poisons.
to all of these things is
the last 70, 80 or 100 years
evolution was going to find
start thinking about them
ABOUT THE SPEAKER
Ramanan Laxminarayan - Drug-resistance economistAt the Center for Disease Dynamics, Economics & Policy, economist Ramanan Laxminarayan looks at big-picture issues of global health.
Why you should listen
Economist Ramanan Laxminarayan works to improve understanding of drug resistance as a problem of managing a shared global resource. As Director and Senior Fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP), he is interested in cross-disciplinary, pragmatic solutions to reduce drug resistance. He has advised the World Health Organization and World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He was a key architect of the Affordable Medicines Facility for malaria, a novel financing mechanism to improve access and delay resistance to antimalarial drugs. In 2012, he created the Immunization Technical Support Unit in India, which has been credited with improving the immunization program in the country. He teaches at Princeton.
As he says: "It has been a long time since people died of untreatable bacterial infections, and the prospect of returning to that world is worrying."Ramanan Laxminarayan | Speaker | TED.com